tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Smith & Nephew Reports Strong Q2 2025 Results and Announces $500 Million Share Buyback

Story Highlights
  • Smith & Nephew reported strong revenue growth and improved cash flow for Q2 2025.
  • The company announced a $500 million share buyback, reflecting strong financial performance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Smith & Nephew Reports Strong Q2 2025 Results and Announces $500 Million Share Buyback

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Smith & Nephew Snats ( (SNN) ) just unveiled an update.

On August 5, 2025, Smith & Nephew announced its second quarter and first half 2025 financial results, showcasing strong revenue growth, trading margin expansion, and improved cash flow. The company reported a 7.8% increase in second-quarter revenue and a 4.7% rise in half-year revenue compared to the previous year. Operating profit surged by 30.6%, and the company generated $244 million in free cash flow. Smith & Nephew also announced a $500 million share buyback, reflecting strong cash generation and a robust balance sheet. The company maintained its full-year guidance, expecting underlying revenue growth of around 5.0% and trading profit margin expansion. Recent product launches have driven growth across all business units, contributing significantly to the company’s financial performance.

The most recent analyst rating on (SNN) stock is a Hold with a $27.27 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.

Spark’s Take on SNN Stock

According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.

Smith & Nephew Snats is well-positioned due to strong financial performance and positive earnings call sentiment, highlighting growth and strategic execution. The technical analysis indicates a strong upward trend, although overbought conditions may pose short-term risks. The high P/E ratio suggests potential overvaluation, but the dividend yield adds some appeal for income-focused investors.

To see Spark’s full report on SNN stock, click here.

More about Smith & Nephew Snats

Smith & Nephew is a global medical technology company that specializes in advanced wound management, orthopaedics, and sports medicine & ENT products. The company focuses on innovation-driven growth and has a strong presence in the medical technology industry.

Average Trading Volume: 856,836

Technical Sentiment Signal: Buy

Current Market Cap: $13.44B

Find detailed analytics on SNN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1